Valsalva SBP Drop and LVOT Obstruction
Recruiting
Observational Study
HCM
oHCM
nHCM
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 800 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aimed to evaluate the efficacy of non-invasive dynamic blood pressure monitoring in assessing left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. We prospectively collected SBP waveforms and LVOT gradient data from patients with obstructive and non-obstructive disease, systematically analyzed their correlation, and explored its clinical value in diff…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:1: ① Age ≥ 18 years
2: ② Diagnosed with hypertrophic cardiomyopathy (HCM) by echocardiography, with or without left ventricular outflow tract obstruction
3: ③ Conscious and mentally competent, able to understand and voluntarily sign the informed consent form
4: ④ Able to cooper…
Contacts